I DON'T MAKE ANY MONEY OFF THIS SITE

If this helps you and you want to make sure it continues, please donate.

Donate
Back to results

Potential Lawsuit: Dupixent T-Cell Lymphoma Lawsuit Information and Legal News

via LawyersAndSettlements Published: Jun 12, 2026

Summary

People filing Dupixent lawsuits allege they developed cutaneous T-cell lymphoma (CTCL) or other forms of T-cell lymphoma after using the medication. Plaintiffs contend that Regeneron Pharmaceuticals and Sanofi failed to warn patients and healthcare providers about a potential cancer risk despite mounting reports and research. And earlier warnings may have prompted additional testing or closer monitoring, potentially leading to earlier diagnoses and treatment

Read full article β†’